Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Unaudited)

v3.19.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Common Stock Dividend Distributable
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Effect of new accounting adoption             $ 255 $ 255
Balance as currently stated at, December 30, 2017 , December 29, 2018 and March 31, 2018 $ 3 $ 37 $ 179,906 $ (7,146)   $ 557 (132,741) 40,616
Beginning balance (in shares) at Dec. 30, 2017 2,771,000 34,666,000            
Beginning balance at Dec. 30, 2017 $ 3 $ 37 179,906 (7,146)   557 (132,996) 40,361
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance as currently stated at, December 30, 2017 ,December 29, 2018 and March 31, 2018 (in shares) 2,771,000 34,939,000            
Net income (loss)             568 568
Issuance of shares in connection with restricted stock units vesting (in shares)   438,000            
Minimum tax withholding on RSU's (in shares)   (166,000)            
Minimum tax withholdings on options exercised     (395)         (395)
Issuance of shares in connection with BOD Fees (in shares)   1,000            
Issuance of shares in connection with BOD Fees     4         4
Share-based compensation     1,002         1,002
Common stock dividend on preferred stock             (39) (39)
Effect of changes in foreign currencies           22   22
Ending balance (in shares) at Mar. 31, 2018 2,771,000 34,939,000            
Ending balance at Mar. 31, 2018 $ 3 $ 37 180,517 (7,146)   579 (132,212) 41,778
Beginning balance (in shares) at Dec. 30, 2017 2,771,000 34,666,000            
Beginning balance at Dec. 30, 2017 $ 3 $ 37 179,906 (7,146)   557 (132,996) 40,361
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)               (409)
Ending balance (in shares) at Sep. 29, 2018 2,771,000 34,985,000            
Ending balance at Sep. 29, 2018 $ 3 $ 37 181,226 (7,146)   612 (133,271) 41,461
Beginning balance (in shares) at Dec. 30, 2017 2,771,000 34,666,000            
Beginning balance at Dec. 30, 2017 $ 3 $ 37 179,906 (7,146)   557 (132,996) 40,361
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance as currently stated at, December 30, 2017 ,December 29, 2018 and March 31, 2018 (in shares) 2,771,000 34,992,000            
Ending balance (in shares) at Dec. 29, 2018 2,771,000 34,992,000            
Ending balance at Dec. 29, 2018 $ 3 $ 38 183,139 (7,146)   579 (137,791) 38,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance as currently stated at, December 30, 2017 , December 29, 2018 and March 31, 2018 $ 3 $ 37 180,517 (7,146)   579 (132,212) 41,778
Beginning balance (in shares) at Mar. 31, 2018 2,771,000 34,939,000            
Beginning balance at Mar. 31, 2018 $ 3 $ 37 180,517 (7,146)   579 (132,212) 41,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)             (797) (797)
Issuance of shares in connection with restricted stock units vesting (in shares)   33,000            
Minimum tax withholding on RSU's     (35)         (35)
Issuance of shares in connection with BOD Fees (in shares)   2,000            
Issuance of shares in connection with BOD Fees     4         4
Share-based compensation     156         156
Common stock dividend on preferred stock             (41) (41)
Effect of changes in foreign currencies           24   24
Ending balance (in shares) at Jun. 30, 2018 2,771,000 34,974,000            
Ending balance at Jun. 30, 2018 $ 3 $ 37 180,642 (7,146)   603 (133,050) 41,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)             (180) (180)
Issuance of shares in connection with restricted stock units vesting (in shares)   9,000            
Issuance of shares in connection with BOD Fees (in shares)   2,000            
Issuance of shares in connection with BOD Fees     4         4
Share-based compensation     580         580
Common stock dividend on preferred stock             (41) (41)
Effect of changes in foreign currencies           9   9
Ending balance (in shares) at Sep. 29, 2018 2,771,000 34,985,000            
Ending balance at Sep. 29, 2018 $ 3 $ 37 181,226 (7,146)   612 (133,271) 41,461
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Effect of new accounting adoption             1,623 1,623
Balance as currently stated at, December 30, 2017 , December 29, 2018 and March 31, 2018 $ 3 $ 38 183,139 (7,146)   579 (136,168) 40,445
Beginning balance (in shares) at Dec. 29, 2018 2,771,000 34,992,000            
Beginning balance at Dec. 29, 2018 $ 3 $ 38 183,139 (7,146)   579 (137,791) 38,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)             (3,581) (3,581)
Issuance of shares in connection with restricted stock units vesting (in shares)   437,000            
Issuance of shares in connection with restricted stock units vesting     (288)         (288)
Issuance of shares in connection with BOD Fees (in shares)   4,000            
Issuance of shares in connection with BOD Fees     4         4
Share-based compensation     554         554
Common stock dividend on preferred stock             (39) (39)
Effect of changes in foreign currencies           (5)   (5)
Ending balance (in shares) at Mar. 30, 2019 2,771,000 35,433,000            
Ending balance at Mar. 30, 2019 $ 3 $ 38 183,409 (7,146)   574 (139,788) 37,090
Beginning balance (in shares) at Dec. 29, 2018 2,771,000 34,992,000            
Beginning balance at Dec. 29, 2018 $ 3 $ 38 183,139 (7,146)   579 (137,791) 38,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)               $ (6,461)
Issuance of shares in connection with stock option exercises (in shares)               100
Ending balance (in shares) at Sep. 28, 2019 2,771,000 35,924,000            
Ending balance at Sep. 28, 2019 $ 3 $ 38 184,992 (7,146) $ 41 560 (142,750) $ 35,738
Beginning balance (in shares) at Mar. 30, 2019 2,771,000 35,433,000            
Beginning balance at Mar. 30, 2019 $ 3 $ 38 183,409 (7,146)   574 (139,788) 37,090
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)             (1,457) (1,457)
Issuance of shares in connection with restricted stock units vesting (in shares)   348,000            
Issuance of shares in connection with restricted stock units vesting     (2)         (2)
Issuance of shares in connection with BOD Fees (in shares)   3,000            
Issuance of shares in connection with BOD Fees     5         5
Share-based compensation     625         625
Common stock dividend on preferred stock         40     40
Issuance of shares related to dividends on preferred stock             (41) (41)
Effect of changes in foreign currencies           (33)   (33)
Ending balance (in shares) at Jun. 29, 2019 2,771,000 35,784,000            
Ending balance at Jun. 29, 2019 $ 3 $ 38 184,037 (7,146) 40 541 (141,286) 36,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss)             (1,424) (1,424)
Issuance of shares in connection with stock option exercises (in shares)   100,000            
Issuance of shares in connection with stock option exercise     100         100
Issuance of shares in connection with restricted stock units vesting (in shares)   2,000            
Issuance of shares in connection with restricted stock units vesting     (2)         (2)
Issuance of shares in connection with BOD Fees (in shares)   5,000            
Issuance of shares in connection with BOD Fees     5         5
Share-based compensation     813         813
Common stock dividend on preferred stock             (40)  
Common stock dividend on preferred stock         40      
Issuance of shares related to dividends on preferred stock (in shares)   33,000            
Issuance of shares related to dividends on preferred stock     39   (39)      
Effect of changes in foreign currencies           19   19
Ending balance (in shares) at Sep. 28, 2019 2,771,000 35,924,000            
Ending balance at Sep. 28, 2019 $ 3 $ 38 $ 184,992 $ (7,146) $ 41 $ 560 $ (142,750) $ 35,738